Symbol Name ID |
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase) MGI:109201 |
Reference
|
J:84738 Cornish VA, Pinter K, Boukouvala S, Johnson N, Labrousse C, Payton M, Priddle H, Smith AJ, Sim E, Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J. 2003;3(3):169-77 |
Age | E9.5 | E11.5 | E12.5 | E15.5 | P |
Immunohistochemistry (section) | |||||
In situ RNA (section) | |||||
Immunohistochemistry (whole mount) | |||||
In situ RNA (whole mount) | |||||
In situ reporter (knock in) | ![]() |
![]() |
![]() |
![]() |
|
Northern blot | |||||
Western blot | ![]() |
||||
RT-PCR | |||||
cDNA clones | |||||
RNase protection | |||||
Nuclease S1 | |||||
Primer Extension |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|